logo
Hand vs Hand: The Strange World of Alien Limb

Hand vs Hand: The Strange World of Alien Limb

Medscape8 hours ago

A 55-year-old patient who was right-handed consulted a neurologist for episodes of inter-manual conflict due to uncontrolled movements of his left hand, marked by involuntary movements of his left hand that interfered with the right hand. Each time he reached for a door handle with his right hand, his left hand counteracted the movement. He reported similar interference during other manual tasks. The patient was anxious and feared the persistence of these movements. A brain MRI prescribed by the neurologist allowed the diagnosis of infarction of the corpus callosum.
This rare case of alien hand syndrome reported by Léonard Kouamé Kouassi, MD, and colleagues at Félix Houphouët-Boigny University in Abidjan, Côte d'Ivoire, recommends brain imaging in case of unusual clinical manifestation or prompt referral of the patient to a neurologist.
The Patient and His History
The right-handed patient had episodes of uncontrolled movements of his left hand. According to him, this phenomenon had been developing for 8 days, preceded by a numbness sensation in his left upper limb 6 days earlier. He is right-handed. Whenever he moves his right hand to perform an activity, his left hand interferes. He has the impression that his left hand is being controlled by someone else, preventing him from performing his activities. These symptoms made him anxious, and he kept asking the neurologist if this hand behaviour would ever stop. His medical history included high blood pressure and type 2 diabetes for at least 5 years. There was no history of alcohol or tobacco use and no family history of hypertension or diabetes.
Findings and Diagnosis
On admission, neurologic examination was normal, blood pressure was 160/100 mm Hg, temperature was 37.2 °C, pulse was 84 beats/min and was regular, weight was 93 kg, and height was 1.76 m. A scheduled neuropsychological evaluation could not be performed.
Complete blood cell count, erythrocyte sedimentation rate, C-reactive protein, urea, and creatinine levels were within the reference range. Only low-density lipoprotein cholesterol was elevated at 1.37 g/dL. The retroviral serology results were negative. The immunological and thrombophilia test results were normal.
Cerebral MRI showed well-systematised signal anomalies within the corpus callosum splenium, extending anteriorly to its trunk, with a discrete mass effect on the corpus callosum body. These anomalies appeared in hyposignal on the T1 sequence, hypersignal on the T2 sequences, and fluid-attenuated inversion recovery in diffusion 1000, without restriction on the apparent diffusion coefficient and without haemorrhagic stigmata in gradient echo, corresponding to images of a relatively recent corpus callosum ischaemic stroke in the territories of the left pericallosal and posterior cerebral arteries. An old punctuated vascular lesion of the left caudate nucleus and acquired leukoencephalopathy of old vascular origin were also noted.
ECG showed sinus tachycardia associated with an incomplete right branch block with a V5-V6 late S-wave. A Holter ECG could not be performed. Transthoracic echocardiography showed concentric hypertrophy of the left ventricular walls and no intracavity thrombus. Transoesophageal echocardiography was non-specific. Doppler ultrasound of supra-aortic trunks showed marked bilateral atheromatosis, with the presence of a non-stenotic heterogeneous plaque at the ostium of the right internal carotid artery.
On the basis of these findings, the patient was diagnosed with alien hand syndrome. The management was that of ischaemic stroke. Medications prescribed to the patient included an antidiabetic by a diabetologist, an antihypertensive (perindopril arginine/amlodipine besylate), a statin (Rosuvastatin EG), an antiplatelet aggregator (aspirin), and an anxiolytic (prazepam). Around 21 days after the onset of the stroke, the patient noted a significant improvement in the behaviour of his left hand, which became less and less troublesome, with the disappearance of the inter-manual conflict. However, the patient reported difficulties in deciding which of the two opposite actions to initiate.
Discussion
Alien hand syndrome is a rare manifestation of stroke. The diagnostic workup followed standard stroke protocols. There is no approved or recommended therapy, and its management is based on anecdotal reports of pharmacological interventions using botulinum toxin and clonazepam, as well as behavioural interventions. In this case, in addition to the usual treatment of cerebral infarction, prazepam is an anxiolytic. Clonazepam and prazepam belong to the same therapeutic group and have similar actions, which may explain the improvement seen in our patient. 'We hope, by updating this syndrome, to attract the attention of physicians to avoid diagnostic delays. In addition, this case report could contribute to enriching data on alien hand syndrome in sub-Saharan Africa,' the authors wrote.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies
Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies

Yahoo

time44 minutes ago

  • Yahoo

Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies

Cloud-based solution monitors temperature and humidity of refrigerators and regulated rooms with real-time alerts to ensure the safety and effectiveness of medications and biologicals NEW YORK, June 17, 2025 /PRNewswire/ -- the industry leader in AI-powered RTLS for care operations, today announced the launch of a new solution that enables hospitals to continuously monitor the temperature and humidity of refrigerators, warmers, and regulated rooms that store condition-sensitive materials such as medications, vaccines, and biologics. Continuous temperature monitoring is essential in hospitals because vaccines and many medications require strict temperature control to maintain safety and effectiveness. Even brief exposure to temperatures outside recommended ranges can significantly compromise medications' potency, rendering them ineffective or unsafe for patient use. The solution utilizes a modern design with monitors that help staff see temperature ranges at a glance with probes that feed data to a cloud-based dashboard, providing real-time alerts and reporting capabilities. This new temp-monitoring solution will help hospitals comply with stringent vaccine storage and handling requirements of the Vaccines for Children program by the U.S. Centers for Disease Control and Prevention (CDC) with simple, easy-to-use reporting for periodic audits. Additionally, the entire system is available with NIST-traceable calibration certificates. By continuously tracking temperatures — with automated 24/7 real-time alerts for peace of mind when staff is unavailable — healthcare facilities can promptly identify and correct any deviations, minimizing the risk of spoilage, reducing waste, and safeguarding critical resources that are often costly and challenging to replace. Ultimately, this enhances patient safety, improves overall care quality, and helps healthcare providers maintain confidence in their clinical practices. As part of Intelligent Orchestration, hospitals can pair the Temperature Monitoring solution with the Asset Tracking solution to have a comprehensive source of data in a single platform to manage critical materials and equipment. "Our new Temperature Monitoring solution underscores commitment to improving hospital operational efficiency and patient care," said Rom Eizenberg, Chief Revenue Officer, "With proactive monitoring and real-time alerts, hospitals can significantly reduce risk, minimize waste, and enhance patient safety, while adhering to regulatory requirements." Continuous temperature monitoring is the newest advancement in Responsive Care Operations platform, which integrates operational and EHR data into a unified solution. Offered as a managed service, the platform utilizes AI-powered RTLS to transform operational data into actionable insights, automation, and real-time decision support—allowing health systems to rapidly realize measurable outcomes and immediate ROI. About is the first platform that gives healthcare systems everything they need to automate and orchestrate care operations. Combining AI-powered RTLS and fully managed IoT infrastructure as a service, enables responsive care and resource deployment. Optimize asset utilization and inventory, improve staff safety and productivity, and reduce length of stay with a platform that enables dozens of use cases along the patient journey. Since 2013, has provided solutions to 32,000+ end users, delivered via 1,200+ partners, and deployed 4+ million IoT devices in the field. Media Contacts:Marcia Rhodes, mrhodes@ Rubi Cohen, View original content to download multimedia: SOURCE Sign in to access your portfolio

This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?

Yahoo

timean hour ago

  • Yahoo

This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?

This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It? originally appeared on Parade. I don't know about you, but when I conceptualize over-the-counter medications, I think they're generally safe for people to take. They don't require a prescription, people take them often, and the list goes some degree, that's true. But it's important to know that over-the-counter (OTC) medication is still medication; it's still going to have side effects and interactions. On that note, doctors want to warn about a particular OTC med that may harm your brain health, the science behind the risk and safer alternatives to consider.🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 The medication ingredients in question are doxylamine succinate, which is found in certain sleep aids (like Unisom) and allergy medications, like first-generation antihistamines (such as hydroxyzine, or Vistaril/Atarax, and diphenhydramine, or Benadryl. It can have cognitive side effects in the long term and short term, though the former are more serious—think increased dementia risk.'Doxylamine succinate, a first-generation antihistamine, can have negative impacts on brain health, especially when patients use high doses, frequently and for a long period,' confirms , an allergist at Memorial impacts, she says, include confusion, drowsiness and dizziness. Prolonged use, however, can lead to cognitive decline, memory loss, increased risk of dementia and delirium, especially in older This 3-Minute Habit Could Help You Sleep Through the Night Dr. Sanjay Kamboj, MD, an associate professor of medicine and an allergy and immunology specialist at LCMC Health, agrees. 'Cumulative use over time may lead to neurodegenerative changes or exacerbate existing risk factors for dementia,' he says. 'Short-term, occasional use of doxylamine in healthy adults is generally considered safe, with mild and temporary side effects such as dry mouth, drowsiness or grogginess.'The former has been noted in research, too: A 2015 study in JAMA Internal Medicine concluded 'higher cumulative anticholinergic use is associated with an increased risk for dementia.' But how does it happen? 'These medications block acetylcholine, a neurotransmitter essential for memory, attention and learning,' explains , sleep science advisor at Aeroflow Sleep, a board-certified sleep medicine physician and a pediatric neurologist. 'Over time, this interference may contribute to structural and functional changes in the brain.' , a clinical pharmacy specialist in UI Health Care's Allergy/Immunology Clinic, adds that 'acetylcholine is a key chemical involved in promoting wakefulness and arousal,' so naturally, when it's blocked, a person might feel drowsy or common risks that doctors mention include daytime drowsiness, cognitive impairment and somnolence, or severe drowsiness. Further, the latter can impair mental alertness and increase the risk of falls or accidents, Dr. McDanel says. Related: New Study Reveals Surprising Factor That May Increase Dementia Risk This is particularly true for older adults who take this medication. 'In older adults, reduced brain reserve makes them more vulnerable to these effects,' Dr. Kamboj explains. In fact, Dr. Nguyen would say it's 'very risky' for elderly patients to take a high dosage of doxylamine succinate for a prolonged period. The level of risk depends on the dose, duration and individual factors, McDanel adds, like age, other medications taken and overall brain health. Within certain parameters, it *can* be safe—and even helpful and recommended. 'Generally speaking, doxylamine can be safe when used in the lowest effective dose for the shortest duration possible,' Dr. McDanel says. 'It is even recommended fairly regularly for pregnant women to help with nausea as it is effective for this, along with vitamin B6, and is safe for the fetus.' Since the safety profile is so individualized, your best bet is to talk to your primary care provider, who knows your history. It's also worth noting that when it comes to sleep, medication may not be the answer we would assume it to be. 'They don't provide the deep, restorative sleep that our brains need,' Dr. Allen says. 'In fact, they can disrupt the natural sleep architecture, leading to less REM sleep, which is crucial for memory consolidation and emotional regulation.' If you need more long-term support with allergies or sleep, other options are probably safer bets. Ahead, doctors share tips and treatments to consider. Try a newer antihistamine, like loratadine (Claritin), cetirizine (Zyrtec) or fexofenadine (Allegra). Dr. Allen says they're generally safer because they don't cross the blood-brain barrier as easily and have fewer side effects. Second-generation antihistamines are also less likely to make you drowsy, a major complaint with first-generation antihistamines. 'Allergists often recommend these over first-generation antihistamines due to the lower chance of causing sedation, while maintaining the same, if not more, clinical efficacy for treating allergic conditions,' Dr. McDanel adds. She also encourages steroid nasal sprays, addressing underlying medical conditions and talking to your healthcare provider. Additionally, Dr. Nguyen mentions prescription medication, such as montelukast, and allergy shots. 'Allergy immunotherapy (allergy shots) is the most effective treatment for moderate to severe allergies,' she adds. Related: FDA Warns of Newly Identified 'Severe' Risk of Popular Over-the-Counter Allergy Medications If you struggle with sleep, Dr. Allen has several suggestions. His first recommendation is cognitive behavioral therapy for insomnia (CBT-I). 'This is the gold standard for chronic sleep problems,' he says. Sleep hygiene is still important too. Need a refresher on what that looks like? Dr. Allen encourages the following: Establishing a consistent sleep routine Limiting screen time before bed Avoiding stimulants late in the day Creating a cool, dark sleeping environment Talking to a doctor about medication (or supplements) if necessary Dr. Nguyen agrees that CBT-I and good sleep habits are good options. 'This is considered the safest way to treat insomnia,' she explains. And again, this long-term concern about doxylamine and brain health doesn't mean the medication is totally off limits. 'Occasional use (e.g., for a bad cold or jet lag) is not known to pose major harm in healthy adults,' Dr. Kamboj says. 'The concern arises with habitual or long-term use, particularly in older individuals.' Up Next:Dr. Duyen Nguyen, DO, an allergist Dr. Sanjay Kamboj, MD, an allergy and immunology specialist Dr. Chris Allen, MD, a board-certified sleep medicine physician and a pediatric neurologist Dr. Deanna McDanel, PharmD, a clinical pharmacy specialist Cumulative Use of Strong Anticholinergics and Incident Dementia, JAMA Internal Medicine This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It? first appeared on Parade on Jun 17, 2025 This story was originally reported by Parade on Jun 17, 2025, where it first appeared.

Changes in Aortic Valve Signal Heart Failure Progression
Changes in Aortic Valve Signal Heart Failure Progression

Medscape

time2 hours ago

  • Medscape

Changes in Aortic Valve Signal Heart Failure Progression

In patients with chronic heart failure (HF), the presence of aortic valve (AV) sclerosis appeared to reflect a more severe disease rather than serve as an independent prognostic factor for poor outcomes. This study suggested that its development should be viewed as a marker of disease progression. METHODOLOGY: Researchers in Italy retrospectively analysed data of 1397 patients with chronic HF (mean age, 65.2 years; 83.4% men) enrolled between September 2006 and December 2019 to determine whether AV sclerosis can predict mortality and cardiovascular outcomes. The patients had a history of HF with reduced ejection fraction or left ventricular ejection fraction < 40%, had stable HF medications for at least 3 months, could perform a cardiopulmonary exercise test, and had no planned major interventions. The presence of AV sclerosis was identified using images from transthoracic echocardiography. The 5-year outcomes of interest were all-cause mortality and cardiovascular outcomes involving a composite of cardiovascular mortality, urgent heart transplant, or implantation of the left ventricular assist device. TAKEAWAY: At baseline, 50.6% of patients had AV sclerosis; they were older and had a higher incidence of ischaemic HF and more severe HF, had worse renal function, and received more medical and device treatments than those without the condition. The presence of AV sclerosis at the time of HF diagnosis was linked to higher risks for all-cause mortality and cardiovascular outcomes; however, this association disappeared after adjusting for confounding factors. Among patients with follow-up echocardiograms, more than 40% developed AV sclerosis, particularly those older in age, with more severe HF, and with ischaemic cardiomyopathy and/or diabetes. Developing AV sclerosis during follow-up was associated with markedly higher risks for all-cause mortality (hazard ratio [HR], 3.7; P = .017) and cardiovascular outcomes (HR, 6.0; P = .020). IN PRACTICE: "Detecting the presence and new development of AV sclerosis could assist physicians in early identifying HF patients who may benefit most from closer clinical follow-up, more intensive therapy, and stricter risk factor control," the authors wrote. SOURCE: This study was led by Veronika A. Myasoedova, MD, PhD, Centro Cardiologico Monzino, Milan, Italy. It was published online on June 06, 2025, in European Heart Journal Open . LIMITATIONS: This retrospective study included only patients who could undergo cardiopulmonary exercise testing, thus limiting the generalisability of the findings to those with more advanced HF. Follow-up echocardiography was available for only 55% of patients. AV sclerosis was expressed as either present or absent without any grading. DISCLOSURES: This study received support from the Italian Ministry of Health funds and Fondazione Gigi e Pupa Ferrari Onlus. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store